Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Raoult, D., Zumla, A., Locatelli, F., Ippolito, G. & Kroemer, G. Coronavirus infections: epidemiological, clinical and immunological features and hypotheses. Cell Stress 4, 66–75 (2020).
Hasegawa, K. et al. Respiratory virus epidemiology among US infants with severe bronchiolitis: analysis of 2 multicenter, multiyear cohort studies. Pediatr. Infect. Dis. J. 38, E180–E183 (2019).
Killerby, M. E. et al. Human coronavirus circulation in the United States 2014–2017. J. Clin. Virol. 101, 52–56 (2018).
Chen, Y., Liu, Q. & Guo, D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J. Med. Virol. 92, 418–423 (2020).
Walsh, E. E., Shin, J. H. & Falsey, A. R. Clinical impact of human coronaviruses 229E and OC43 infection in diverse adult populations. J. Infect. Dis. 208, 1634–1642 (2013).
Varghese, L. et al. Epidemiology and clinical features of human coronaviruses in the pediatric population. J. Pediatr. Infect. Dis. Soc. 7, 151–158 (2018).
Fielding, B. C. Human coronavirus NL63: a clinically important virus? Future Microbiol. 6, 153–159 (2011).
Ralston, S. L. et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics 134, e1474–e1502 (2014).
Stewart, C. J. et al. Respiratory syncytial virus and rhinovirus bronchiolitis are associated with distinct metabolic pathways. J. Infect. Dis. 217, 1160–1169 (2018).
Fujiogi, M. et al. Association of rhinovirus species with nasopharyngeal metabolome in bronchiolitisinfants: a multicenterstudy. Allergy https://doi.org/10.1111/all.14326 (2020).
Hasegawa, K. et al. Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalised for bronchiolitis. Eur. Respir. J. 48, 1329–1339 (2016).
Rohart, F., Gautier, B., Singh, A. & Le Cao, K.-A. mixOmics: an R package for’omics feature selection and multiple data integration. PLoS Comput. Biol. 13, e1005752 (2017).
Fujiogi, M. et al. In infants with severe bronchiolitis: dual-transcriptomic profiling of nasopharyngeal microbiome and host response. Pediatr. Res. https://doi.org/10.1038/s41390-019-0742-e1005758 (2020).
Toivonen, L. et al. Association between rhinovirus species and nasopharyngeal microbiota in infants with severe bronchiolitis. J. Allergy Clin. Immunol. 143, 1925–1928.e7 (2019).
Rosas-Salazar, C. et al. Differences in the nasopharyngeal microbiome during acute respiratory tract infection with human rhinovirus and respiratory syncytial virus in infancy. J. Infect. Dis. 214, 1924–1928 (2016).
Braverman, N. E. & Moser, A. B. Functions of plasmalogen lipids in health and disease. Biochim. Biophys. Acta 1822, 1442–1452 (2012).
Rüdiger, M., Von Baehr, A., Haupt, R., Wauer, R. R. & Rüstow, B. Preterm infants with high polyunsaturated fatty acid and plasmalogen content in tracheal aspirates develop bronchopulmonary dysplasia less often. Crit. Care Med. 28, 1572–1577 (2000).
Sturgill, J. L. Sphingolipids and their enigmatic role in asthma. Adv. Biol. Regul. 70, 74–81 (2018).
Poole, A. et al. Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease. J. Allergy Clin. Immunol. 133, 670–678.e12 (2014).
Marsh, R. L. et al. The microbiota in bronchoalveolar lavage from young children with chronic lung disease includes taxa present in both the oropharynx and nasopharynx. Microbiome 4, 1–18 (2016).
Acknowledgements
We thank the MARC-35 study hospitals and research personnel for their ongoing dedication to bronchiolitis and asthma research (Table E1 in the Online Supplement), and Janice A. Espinola, MPH and Ashley F. Sullivan, MS, MPH (Massachusetts General Hospital, Boston, MA) for their many contributions to the MARC-35 study. We also thank Alkis Togias, MD, at the National Institutes of Health (Bethesda, MD) for helpful comments about the study results. The current study is supported by grants from the National Institutes of Health (Bethesda, MD): R01 AI-127507, R01 AI-134940, R01 AI-137091, and UG3/UH3 OD-023253. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Author information
Authors and Affiliations
Contributions
M.F. carried out the statistical analysis, drafted the initial manuscript, revised the manuscript, and approved the final manuscript as submitted. C.A.C. and K.H. conceptualized and designed the study, obtained the funding, reviewed and revised the manuscript, and approved the final manuscript as submitted. Y.R. and L.T. assisted in the statistical analysis, reviewed and revised the manuscript, and approved the final manuscript as submitted. R.J.F. conceptualized the study, reviewed and revised the manuscript, and approved the final manuscript as submitted. J.M.M. collected the study data, reviewed and revised the manuscript, and approved the final manuscript as submitted. P.A.P. generated virus data, reviewed and revised the manuscript, and approved the final manuscript as submitted.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Fujiogi, M., Camargo, C.A., Raita, Y. et al. Association of endemic coronaviruses with nasopharyngeal metabolome and microbiota among infants with severe bronchiolitis: a prospective multicenter study. Pediatr Res 89, 1594–1597 (2021). https://doi.org/10.1038/s41390-020-01154-2
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41390-020-01154-2
